Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Myomo (MYO) Revenue (2016 - 2025)

Myomo filings provide 10 years of Revenue readings, the most recent being $10.1 million for Q3 2025.

  • On a quarterly basis, Revenue rose 9.59% to $10.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was $41.6 million, a 64.99% increase, with the full-year FY2024 number at $32.6 million, up 69.17% from a year prior.
  • Revenue hit $10.1 million in Q3 2025 for Myomo, up from $9.7 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $12.1 million in Q4 2024 to a low of $2.3 million in Q1 2021.
  • Median Revenue over the past 5 years was $4.4 million (2021), compared with a mean of $5.8 million.
  • Biggest five-year swings in Revenue: surged 261.56% in 2021 and later decreased 10.89% in 2023.
  • Myomo's Revenue stood at $4.0 million in 2021, then increased by 0.25% to $4.0 million in 2022, then grew by 17.69% to $4.8 million in 2023, then soared by 153.73% to $12.1 million in 2024, then fell by 16.39% to $10.1 million in 2025.
  • The last three reported values for Revenue were $10.1 million (Q3 2025), $9.7 million (Q2 2025), and $9.8 million (Q1 2025) per Business Quant data.